US business broker averts LOI re-trade on a healthcare services acquisition after pre-sale cyber diligence.

An American mid-market business broker representing the seller in a healthcare services acquisition engaged LeakTrace to run pre-sale cyber diligence before the buyer's cyber diligence commenced. A comparable listing at the broker's firm had re-traded at the letter-of-intent stage the prior quarter when buyer-side diligence surfaced HIPAA-adjacent exposure the seller had not disclosed. The broker did not want to repeat that outcome.

Engagement origin

The seller was a mid-market American healthcare services company with approximately one hundred twenty clinical and administrative staff across three offices in two states. The letter of intent had been signed with a strategic buyer at an enterprise value the broker described as materially above the market for comparable transactions in the segment. The broker's concern was that the buyer's cyber diligence team, a well-known firm in the healthcare acquisition channel, would identify exposure conditions and use them to negotiate a working-capital adjustment or an indemnity carve-out that eroded the letter-of-intent economics. The broker engaged LeakTrace on the seller's behalf, with the seller's authorization and its counsel's participation on scope confirmation.

Discovery scope

LeakTrace conducted a seventy-two-hour external attack surface audit covering the seller's registered domains, senior clinical and administrative email patterns, public web presence, and the vendor mapping visible through DNS and certificate transparency records. Public directory records associated with the seller's National Provider Identifier registrations and state-level clinical licensure filings were reviewed for exposure conditions relevant to Health Insurance Portability and Accountability Act obligations. The engagement did not touch the seller's internal systems and was scoped to complete before the buyer's cyber diligence engagement commenced.

Findings summary

• Clinical staff credential exposure. Multiple clinical email addresses were identified across breach databases actively monitored by threat actors. Three matched the seller's electronic health record login pattern. Under a current risk-of-harm evaluation, these would have triggered HIPAA breach notification analysis if the seller's counsel had reviewed them.
• Legacy authentication surface. A public-facing patient scheduling system disclosed a legacy authentication endpoint that was reachable without geographic access controls, running on a release the vendor had deprecated in the prior year.
• Third-party clinical service breach history. DNS and public procurement filings identified a specialty clinical services vendor the seller had integrated into its clinical workflow. The vendor had been named in a widely-reported security incident in the recent past, and the business associate agreement referenced in the seller's compliance documentation predated the vendor's post-incident security posture upgrade.
• Buyer-side comparability signal. The same buyer's prior comparable acquisition had disclosed cyber diligence findings in its post-close regulatory filings that clustered around the exact patterns identified in this seller's exposure. The buyer's cyber diligence team was known to press on these specific conditions.

Seller actions

The seller executed a remediation program before the buyer's diligence engagement began. Clinical credentials appearing in the breach index were rotated and multi-factor authentication was enforced across the electronic health record platform. The legacy authentication endpoint was decommissioned and geographic controls were configured on the replacement. The specialty clinical services vendor business associate agreement was renegotiated with tighter breach notification and audit rights, and the seller's compliance officer documented the review process. The seller's counsel executed a HIPAA risk-of-harm assessment on the credentials identified and filed the assessment as pre-transaction documentation.

Outcome

The buyer's cyber diligence team completed its engagement in the standard three-week window. The diligence report identified substantively the same exposure conditions LeakTrace had already documented and remediated. Because the remediation was pre-transaction and documented in the seller's data room, the buyer did not request a working-capital adjustment, did not require a cyber-specific indemnity carve-out beyond the standard indemnity structure, and did not delay the closing timeline. The closing occurred at the letter-of-intent enterprise value. The broker later engaged LeakTrace as a standing pre-sale referral partner on healthcare and healthcare-adjacent listings in the same channel.